- Home
- ONEG vs HSCS Comparison
ONEG vs HSCS Comparison
Compare ONEG & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONEG | HSCS |
|---|---|---|
| Founded | 2021 | 2007 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.5M | 15.8M |
| IPO Year | 2024 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ONEG | HSCS |
|---|---|---|
| Price | $1.44 | $3.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 42.2K | ★ 108.6K |
| Earning Date | 07-23-2026 | 12-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.84 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,319.00 |
| Revenue This Year | N/A | $295.93 |
| Revenue Next Year | N/A | $18,321.05 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.64 | $1.63 |
| 52 Week High | $14.95 | $5.25 |
Technical Indicators
Market Signals| Indicator | ONEG | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 77.03 | 49.08 |
| Support Level | $0.95 | $3.25 |
| Resistance Level | $2.00 | $3.71 |
| Average True Range (ATR) | 0.15 | 0.29 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 72.08 | 63.28 |
Price Performance
Historical ComparisonAbout ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction projects include performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.